Loading data
VRCANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 35.58 m USD | 7.57 m USD | 5.12 m USD | 9.03 m USD | 12 m USD |
| Cost of revenue | — | 2.6 m USD | 500 k USD | — | — |
| Research and development expense | 8.86 m USD | 11.84 m USD | 20.3 m USD | 12.2 m USD | 15.93 m USD |
| Selling, general and administrative expense | 35.22 m USD | 58.82 m USD | 47.31 m USD | 17.41 m USD | — |
| Operating profit | -12.19 m USD | -65.92 m USD | -65.76 m USD | -21.3 m USD | -30.91 m USD |
| Interest expense | — | — | 3.96 m USD | 2.17 m USD | 4.3 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | — |
| Net income (reported basis) | -17.9 m USD | -76.6 m USD | -67 m USD | -24.5 m USD | -35.08 m USD |
| Basic earnings per share | -1.68 USD/share | -14.78 USD/share | -1.48 USD/share | -0.72 USD/share | -1.3 USD/share |
| Diluted earnings per share | -1.68 USD/share | -14.78 USD/share | -1.48 USD/share | -0.72 USD/share | -1.3 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.